心脏MRI衍生细胞外容积分数与增强后T1 mapping心肌-管腔R1比值检测心脏淀粉样变性的比较
该回顾性研究纳入2017年3月至2021年7月因已知或疑似心力衰竭或心肌病行MRI细胞外容积分数(MRI ECV)分析的连续患者352例,其中136例为心脏淀粉样变性。增强后T1 mapping心肌-管腔R1比值检测心脏淀粉样变性的诊断性能与MRI ECV相当,曲线下面积无显著差异(P = .10)。
要点
- 增强后T1 mapping心肌-管腔R1比值无需原始T1图和红细胞压积数据即可检测心脏淀粉样变性。
- R1比值截断值0.84时敏感度92.6%、特异度93.1%,AUC 0.98。
- MRI ECV截断值40%时敏感度89.0%、特异度98.6%,AUC 0.99,两者AUC无显著差异。
核心结论
- 增强后心肌-管腔R1比值在检测心脏淀粉样变性方面显示出与MRI ECV相当的优异诊断性能。
研究设计与样本
- 回顾性研究纳入2017年3月至2021年7月因已知或疑似心力衰竭或心肌病行MRI ECV分析的连续患者352例(平均年龄63岁±16[SD],235例男性),采用改良Look-Locker反转恢复序列生成增强前后T1 mapping。
诊断标准与关键数值
- MRI ECV截断值40%时检测心脏淀粉样变性的敏感度89.0%(121/136;95% CI:82%,94%)、特异度98.6%(213/216;95% CI:96%,100%),AUC 0.99(95% CI:0.97,1.00;P < .001);增强后心肌-管腔R1比值截断值0.84时敏感度92.6%(126/136;95% CI:89%,96%)、特异度93.1%(201/216;95% CI:89%,96%),AUC 0.98(95% CI:0.95,0.99;P < .001);两者AUC无显著差异(P = .10)。
临床应用与阅片要点
- 作者结论认为增强后心肌-管腔R1比值诊断性能与MRI ECV相当,该简化指标无需原始T1图和红细胞压积水平数据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the diagnostic performance of myocardium-to-lumen R1 (1/T1) ratio on postcontrast T1 maps for the detection of cardiac amyloidosis in a large patient sample.
MATERIALS AND METHODS: This retrospective study included consecutive patients who underwent MRI-derived extracellular volume fraction (MRI ECV) analysis between March 2017 and July 2021 because of known or suspected heart failure or cardiomyopathy. Pre- and postcontrast T1 maps were generated using the modified Look-Locker inversion recovery sequence. Diagnostic performances of MRI ECV and myocardium-to-lumen R1 ratio on postcontrast T1 maps (a simplified index not requiring a native T1 map and hematocrit level data) for detecting cardiac amyloidosis were evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity.
RESULTS: Of 352 patients (mean age, 63 years ± 16 [SD]; 235 men), 136 had cardiac amyloidosis. MRI ECV showed 89.0% (121 of 136; 95% CI: 82%, 94%) sensitivity and 98.6% (213 of 216; 95% CI: 96%, 100%) specificity for helping detect cardiac amyloidosis (cutoff value of 40% [AUC, 0.99 {95% CI: 0.97, 1.00}; P < .001]). Postcontrast myocardium-to-lumen R1 ratio showed 92.6% (126 of 136; 95% CI: 89%, 96%) sensitivity and 93.1% (201 of 216; 95% CI: 89%, 96%) specificity (cutoff value of 0.84 [AUC, 0.98 {95% CI: 0.95, 0.99}; P < .001]). There was no evidence of a difference in AUCs for each parameter (P = .10).
CONCLUSION: Postcontrast myocardium-to-lumen R1 ratio showed excellent diagnostic performance comparable to that of MRI ECV in the detection of cardiac amyloidosis.Keywords: MR Imaging, Cardiac, Heart, Cardiomyopathies Supplemental material is available for this article. © RSNA, 2023.
引用
- Kidoh M, Oda S, Takashio S, et al. Cardiac MRI-derived Extracellular Volume Fraction versus Myocardium-to-Lumen R1 Ratio at Postcontrast T1 Mapping for Detecting Cardiac Amyloidosis. Radiol Cardiothorac Imaging. 2023. PMID: 37124644. doi:10.1148/ryct.220327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。